☆
Watchlist
Log in
Sign-up
Nanollose Ltd (nc6) Logo

Nanollose Ltd (NC6)

___:___ · Healthcare
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials (10-yr)

NC6 Chart

Snapshot

NC6's Principal Activity is the research and development, and promotion of the Company�??s microbial cellulose technology. The primary focus has been directed towards the development, scale up and ultimate commercialisation of the Company�??s Plant-Free rayon fibre for use in textiles (nullarborTM) and non-woven applications (nufolium�??).

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -4.68%
vs ASX 200 (1yr) -8.39%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,963 of 2,413
Sector Rank 177 of 210

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies TRP / CTQ / GLH
EPS -$0.012
DPS $0.00
Book Value Per Share $0.02

Broker Consensus

NC6 is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Top Market Index News

More News

Announcements

Date Heading Pages File Size Time

Corporate Overview

Nanollose Limited (NC6) is an Australian based biotechnology company that deals in the research and development, and promotion of the Company's microbial cellulose technology. The primary focus has been directed towards the development of the Company's Plant-Free viscose-rayon fibre (Nullarbor). The Company also continued its activities towards developing a commercial supply chain of microbial cellulose from a variety of waste streams.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office Nedlands WA 6009
Website www.nanollose.com
Registry Automic Group
Auditor RSM Australia Partners
Date Listed 18 Oct 2017

Upcoming Calendar (Forecasted)

Date Event
29/08/2022 Report (Prelim)
29/08/2022 Report (Annual)
19/10/2022 Report (Annual)
21/02/2023 Report (Interim)

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.
Show All

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Ms Heidi Beatty Non-Executive Director Jul 2019

Ms Heidi Beatty

Non-Executive Director

Ms Beatty, founder of Crown Abbey Ltd is a scientist and innovator who has 20 years' experience developing consumer and health care products. She worked with Johnson & Johnson for 10 years in Europe and the US. In 2015 she founded Crown Abbey Ltd, a consultancy company that supports clients in their project launches, combining Project Management and Product Development across Consumer and Healthcare categories.

Mr Terence (Terry) Walsh Non-Executive Director Aug 2016

Mr Terence (Terry) Walsh

Non-Executive Director

Mr Walsh is a senior commercial lawyer and manager with more than 20 years of experience in project development, mining and general commercial law. He initially worked with leading law firms in Perth and Sydney before moving in house, where he has worked as the General Counsel of Hancock Prospecting Pty Ltd and prior to that as a Corporate Counsel with Rio Tinto Ltd. In these roles he has been involved with the legal and commercial aspects associated with the development and operation of technology and mining projects.

Dr Wayne Morris Best Executive Chairman,Executive Director Sep 2014

Dr Wayne Morris Best

Executive Chairman,Executive Director

Dr Best has 40 years' experience in organic chemistry both in academia, government and industry. He then spent two years at Imperial College in the UK where he obtained a DIC, followed by a year at the Australian National University in Canberra. He then took up a position with ICI Australia's Research Group in Melbourne for four and a half years which included a secondment to ICI Agrochemicals in the UK. Following ICI, he returned to Western Australia and spent ten years at the Chemistry Centre (WA) where he was responsible for the formation and running of the Medicinal & Biological Chemistry Section which undertook collaborative R&D into drug discovery and contract synthesis for the drug discovery and pharmaceutical industries. He then founded Epichem Pty Ltd, a contract research and drug discovery Company, which he managed for 14 years before moving full-time to Nanollose in 2018 He has served as a Director for several listed and unlisted biotechnology companies. He was a former director of Pharmaust Limited.

Mr Winton William Willesee Non-Executive Director Sep 2014

Mr Winton William Willesee

Non-Executive Director

Mr Willesee is an experienced company director and secretary with over 20 years' experience in various roles within the Australian capital markets. Mr Willesee has considerable experience with ASX listed and other companies over a broad range of industries having been involved with many successful ventures from early stage through to large capital development projects. He has a core expertise in strategy, company development, corporate governance, company public listings, merger and acquisition transactions and corporate finance

Ms Erlyn Dale Company Secretary N/A
Show All

Director Transactions

NC6 directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
17/05/22 Terence (Terry) Walsh Buy +197,168 $0.09 $17,665 On-market trade
31/12/21 Wayne Best Expiry 2,000,000 $0.10 $200,000 As advised by the company
07/12/21 Winton Willesee Buy +500,000 $0.105 $52,500 As advised by the company
07/12/21 Terence (Terry) Walsh Buy +500,000 $0.105 $52,500 As advised by the company
14/01/21 Winton Willesee Buy +170,000 $0.083 $14,110 On-market trade
04/12/20 Raffaele (Alfie) Germano Issued 2,000,000 $0.049 $98,000 Director remuneration
04/12/20 Raffaele (Alfie) Germano Issued 146,796 $0.026 $3,750 Director remuneration
04/12/20 Raffaele (Alfie) Germano Issued 500,000 $0.049 $24,500 Conversion of securities
04/12/20 Raffaele (Alfie) Germano Exercise 500,000 $0.049 $24,500 Conversion of securities
04/12/20 Terence (Terry) Walsh Issued 68,504 $0.026 $1,750 Director remuneration
04/12/20 Winton Willesee Issued 68,504 $0.026 $1,750 Director remuneration
04/12/20 Heidi Beatty Issued 500,000 $0.049 $24,500 Director remuneration
04/12/20 Heidi Beatty Issued 68,504 $0.026 $1,750 Director remuneration
04/12/20 Wayne Best Issued 2,000,000 $0.049 $98,000 Director remuneration
04/12/20 Wayne Best Issued 146,796 $0.026 $3,750 Director remuneration
13/05/20 Winton Willesee Issued 2,237,143 $0.024 $53,691 Rights issue
13/05/20 Wayne Best Issued 2,367,144 $0.024 $56,811 Rights issue
13/05/20 Terence (Terry) Walsh Issued 200,000 $0.024 $4,800 Rights issue
13/05/20 Raffaele (Alfie) Germano Issued 200,000 $0.024 $4,800 Rights issue
20/11/19 Wayne Best Issued 2,000,000 $0.071 $142,000 Issue of securities
20/11/19 Raffaele (Alfie) Germano Issued 2,000,000 $0.071 $142,000 Issue of securities
Show All

Director Interests

The current holdings of NC6 directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Terence (Terry) Walsh 17/05/2022 700,000 265,672 500,000 N/A
Winton Willesee 07/12/2021 N/A 8,068,504 500,000 N/A
Heidi Beatty 30/06/2021 68,504 N/A 500,000 N/A
Wayne Best 30/06/2021 N/A 8,431,798 N/A N/A
Show All

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 19, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Wayne Morris Best <Wayne & Debra Best Fam A/C> 8,431,798 5.67%
Azalea Family Holdings Pty Ltd 8,000,000 5.38%
Mr Jason Duncan Maclaurin 6,351,190 4.27%
Mr John Moursounidis <Moursounidis Family A/C> 5,934,523 3.99%
Mrs Suzanne Margaret Cass <Cass A/C> 4,231,977 2.85%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp> 4,231,504 2.85%
Mr Jonathan James Hunter & Mrs Rebecca Mei Liang Hunter <Hhc Equities Superfund A/C> 3,280,000 2.21%
Citicorp Nominees Pty Limited 2,596,514 1.75%
Mr Michael Hilton Holbrook 2,361,470 1.59%
Tripit Pty Ltd <Peter Heather Wells S/F A/C> 2,060,000 1.39%
Madeiros Pty Ltd <Visser Super Fund A/C> 1,760,826 1.18%
10 Bolivianos Pty Ltd 1,694,834 1.14%
Mr Adam Laurence Bode 1,500,000 1.01%
Germano Mcinally Pty Ltd 1,346,796 0.91%
Mr Bill Chia-Han Chang 1,219,761 0.82%
Mr Andreas Steinwachs 1,184,111 0.80%
Mr David Robin Lunn & Mrs Stephanie Ann Yu <Lunn Superfund A/C> 1,074,729 0.72%
Mr Dean Anthony Mackenzie 1,001,000 0.67%
Vageli Panagiotidis 1,000,000 0.67%
Primaclass Consulting Pty Ltd <Primaclass Super Fund A/C> 1,000,000 0.67%
Mr Zhiyu Ning 900,000 0.61%
Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 30 201 271 796 227 1,525

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Name Last Notice Total Shares Shares Held (%)
Azalea Family Holdings Pty Ltd 19/08/2021 8,068,504 5.43
Wayne Best 19/08/2021 8,431,798 5.67

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
24-06-21 Wayne Best 2,913,941 7.36 5.67
24-06-21 Azalea Family Holdings Pty Ltd 2,550,647 7.36 5.43

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2021 $0.089 30 June
2020 $0.04 30 June
2019 $0.047 28 June
2018 $0.13 29 June
NC6 Historical Price Data (CSV)
Up to 20 years of EOD share price history
Sign up to Download
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.